Racial disparity in breast cancer explained

Key points
- High blood pressure accounts for some of the disproportionately higher mortality rates among African American women with breast cancer compared with their Caucasian counterparts, according to an article in the International Journal of Cancer.
- To examine coexisting conditions that may be involved in this disparity, Dr.
- During an average follow-up of 8.9 years, the overall mortality was 39.7 percent among the black women and 33.3 percent among the white women.
- After controlling for tumor characteristics, breast cancer treatment, age, and race, hypertension was significantly associated with mortality from any cause.
High blood pressure accounts for some of the disproportionately higher mortality rates among African American women with breast cancer compared with their Caucasian counterparts, according to an article in the International Journal of Cancer.
To examine coexisting conditions that may be involved in this disparity, Dr. Dejana Braithwaite at the University of California, San Francisco, and co-investigators analyzed data for women with invasive breast cancer treated at Kaiser Permanente in Northern California between 1973 and 1986 and followed through 1999. There were 416 African-American patients and 838 white patients.
During an average follow-up of 8.9 years, the overall mortality was 39.7 percent among the black women and 33.3 percent among the white women. The corresponding breast cancer mortality was 28.6 percent and 21.6 percent African-Americans also had higher rates of hypertension (43.3 percent vs 28.3 percent.)
After controlling for tumor characteristics, breast cancer treatment, age, and race, hypertension was significantly associated with mortality from any cause. This one factor explained 30.3 percent of racial disparity in all-cause survival," as well as 20.0 percent of the racial disparity in breast cancer-specific survival, Braithwaite s group reports.
The investigators add, "our results nevertheless suggest that hypertension is an important comorbidity to consider in the context of research on racial disparity in breast cancer and our findings warrant its inclusion in comorbidity measures like the Charlson Comorbidity Index."
Furthermore, "better management of hypertension has potential to improve patient outcomes, particularly among African-American breast cancer patients," Braithwaite comments in a UCSF statement.
SOURCE: International Journal of Cancer, March 1, 2009.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNonrecommended screenings for prostate, breast cancer in older individuals
An estimated 15.7 percent of individuals 65 or older may have received nonrecommended screenings for prostate and breast cancers because they had limited life expectancies of less than 10 years, according to an article…
22 January 2016
GuideNew method for better treatment of breast cancer
A new study shows that a novel imaging-based method for defining appropriateness of breast cancer treatment is as accurate as the current standard-of-care and could reduce the need for invasive tissue sampling. The…
31 December 2015
NewsT cells that recognize HER2 teceptor may prevent HER2+ breast cancer recurrence
Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer-induced weakness in the patient's immune system - a weakness that in principle could be corrected with a…


